Leading clinical trials for cancer treatment at the University of Chicago
UG1 - NCTN (Network Lead)
This study is all about giving adults with different types of cancer a chance to join exciting new trials at the University of Chicago Medicine, where they can try out the latest treatments and help shape the future of cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10804625 on NIH RePORTER |
What this research studies
This research focuses on the University of Chicago Medicine Comprehensive Cancer Center's role as a Lead Academic Participating Site in the National Clinical Trials Network. It aims to develop and conduct innovative clinical trials for adults with various types of cancer, utilizing a multidisciplinary approach. The center will leverage its extensive experience and infrastructure to design trials that could change clinical practice, while also mentoring the next generation of researchers in oncology. Patients may have the opportunity to participate in cutting-edge trials that test new treatments and therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults diagnosed with various types of cancer who are seeking innovative treatment options.
Not a fit: Patients with non-malignant conditions or those who do not have access to the University of Chicago may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatments for adults with cancer.
How similar studies have performed: Previous research within the National Clinical Trials Network has shown success in developing effective cancer treatments through similar collaborative approaches.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Kindler, Hedy L — University of Chicago
- Study coordinator: Kindler, Hedy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.